Decision Resources Group

Brian Corvino serves as the Managing Partner and SVP within DRGs Global Services Division. Mr. Corvino has over a decade of experience helping life sciences organizations on issues related to market access, pricing and commercialization strategy. In particular, he has focused primarily in the areas of market access, organized customer segments and specialty biopharmaceuticals, having focused on not only supporting clients with domain expertise but also supporting organizational change processes associated within the new healthcare environment. Brian co-leads global engagements regularly and has a strong understanding of the P&MA environment across Europe

Brian served as the Managing Partner for PharmaStrat, since 2004. PharmaStrat was acquired by DRG in 2011. Prior to joining PharmaStrat (now part of DRG), Mr. Corvino worked at Janssen Pharmaceutical (A division of Johnson & Johnson), where he held positions in specialty sales and business information/analytics and strategic planning analysis.

Mr. Corvino has been a guest lecturer on various issues related to pharmaceutical pricing and market access, at both the graduate and undergraduate levels. Mr. Corvino is a frequent guest lecturer at the Wharton Business School (University of Pennsylvania), Columbia Business School, Rutgers, University of the Sciences and Moravian College, and has been recognized by PharmaVoice as one of the “100 Most Inspiring Leaders in the BioPharmaceutical Industry in 2008."

Mr. Corvino earned a BA, with Honors distinction, from Moravian College, in Bethlehem, PA. In addition, Mr. Corvino has completed graduate executive coursework at the Harvard Business School and received his MBA from Wharton Business School at the University of Pennsylvania.

John Stahl, a Partner with DRG Consulting, leverages a broad range of market access and commercialization experience to effectively deliver strategic and actionable insights to biopharmaceutical and med tech clients. John has responsibility for various areas of strategic consulting and primary research initiatives, and his experience has focused primarily on market access, contracting, and pricing strategies across a range of conditions including rare diseases, neurology, oncology, and traditional small molecule segments.

Prior to joining DRGC, John spent over ten years in the pharmaceutical industry working for Johnson & Johnson and Novartis, in a variety of positions of increasing responsibility, including business analytics, business development, sales, marketing, and managed markets.

John graduated from Duke University with a B.A. in Economics and a B.A. in German. He also completed the Certificate program in Markets and Management Studies.

Jason Ward, a Partner within DRG’s Global Services Division, has extensive experience in the pricing and market access of pharmaceuticals at all stages of development and across many disease areas. He has delivered projects focusing on innovative pricing approaches at portfolio and individual brand level, including across indications.

Jason joined DRG Consulting after spending over two years at IMS Consulting Group, where he was a Senior Principal in the Pricing & Market Access Centre of Excellence. He was responsible for selling and delivering pricing and market access projects across all disciplines and therapy areas for a wide variety of global P&MA clients. He also co-led global P&MA Thought Leadership activities.

Jason joined IMS after 11 years at AstraZeneca, predominantly undertaking global P&MA roles, first as an individual contributor to many brand teams, and then as a team leader, responsible for the P&MA strategies for AZ’s R&D and pre-launch portfolio.

Jason has experience across many disease areas and all stages of drug development and commercialization. He has a special interest in drug development, spending five years at AZ focusing on how to build the views of payers into R&D plans and clinical trial programs.

Sondra vanderVaart is a Director with DRG Consulting. Sondra’s work has focused on extracting actionable insights from data in order to maximize success in the healthcare market place. Her specific area of focus is to support leading biopharmaceutical companies on issues related to commercialization strategy, product and portfolio development, and market access. During her tenure at DRG, Sondra has been instrumental in broadening the company’s expertise in opportunity assessments, payer & provider segmentation, quantitative market modeling and choice-based modeling.

Prior to joining DRGC, Sondra worked at IMS Health for over a decade and at insync. Sondra brings over 15 years of life sciences consulting experience to her role at DRGC and has worked in a variety of therapeutic and diagnostic areas (CV, Diabetes, Diabetic Retinopathy, Crohn’s Disease, COPD and rare diseases).

Sondra has spoken at numerous marketing sciences conferences on novel quantitative methods to aid in product commercialization strategy and is a guest lecturer at the University of Toronto.

Sondra completed an PhD in Pharmacy at the University of Toronto, and an MBA from McGill University. She has published numerous papers in peer-reviewed journals, including her thesis paper which was published in the BMJ.